Cyclo(-RGDfK) TFA

An inhibitor of αvβ3 integrin

此产品仅用于科学研究，我们不为任何个人用途提供产品和服务

库存: 现货

可选规格

包装

价格

促销价

数量
5mg

￥1250.00

1000.00

- +
10mg

￥1962.00

1570.00

- +
50mg

￥7012.00

5610.00

- +

已选 0 种 0 瓶

金额: ￥0.00

首页收藏

货号: ajcx29248
CAS: 500577-51-5
别名:
分子式: C29H42F3N9O9
分子量: 717.69
纯度: >98%
溶解度: DMSO: 100 mg/mL (139.34 mM); Water: 33.33 mg/mL (46.44 mM)
储存: Store at -20°C
库存: 现货

Background

Cyclo(RGDfK) is a synthetic lipopeptide inhibitor of αvβ3 integrin (IC₅₀ = 1.33 nM).¹ Osteoblast cultures, which express αvβ5 and αvβ3 integrins, but not M21L cells that do not express these integrins, bind to cyclo(RGDfK)-coated surfaces. Cyclo(RGDfK) is taken up into tumors in vivo and in vitro and it has been polymerized or conjugated to various fluorophores, radiolabels, and peptide sequences for use in fluorescent and PET imaging to study tumor cell adhesion.^2,3,1

1.?ime?ek, J., Notni, J., Kapp, T.G., et al.Benefits of NOPO as chelator in gallium-68 peptides, exemplified by preclinical characterization of 68Ga-NOPO-c(RGDfK)Mol. Pharm.11(5)1687-1695(2014) 2.Dijkgraaf, I., Beer, A.J., and Wester, H.-J.Application of RGD-containing peptides as imaging probes for alphavbeta3 expressionFront. Biosci. (Landmark Ed.)14(3)887-899(2009) 3.Janssen, M., Oyen, W.J.G., Massuger, L.F.A.G., et al.Comparison of a monomeric and dimeric radiolabeled RGD-peptide for tumor targetingCancer Biother. Radiopharm.17(6)641-646(2002)